Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
07/17/2003 | WO2003057904A1 Method of colorimetry and reagent for use therein |
07/17/2003 | WO2003057882A1 METHOD OF IDENTIFYING PROTEINS CAMs (CONSTITUTIVELY ACTIVE MUTANTS) |
07/17/2003 | WO2003057880A1 Method of quantifying nucleic acid and kit for quantifying nucleic acid |
07/17/2003 | WO2003057879A1 Novel udp-n-acetyl-d-galactosamine:polypeptide n-acetylgalactosamine transferase and nucleic acid encoding the same |
07/17/2003 | WO2003057876A1 Method of screening multiple squamous carcinoma risk group |
07/17/2003 | WO2003057873A1 Plastic plate and plastic plate assembly |
07/17/2003 | WO2003057870A1 Human phosphatidic acid phosphatase type 2-like protein |
07/17/2003 | WO2003057854A2 Novel proteins and nucleic acids encoding same |
07/17/2003 | WO2003057851A2 Binding proteins as biosensors |
07/17/2003 | WO2003057850A2 Binding proteins as biosensors |
07/17/2003 | WO2003057845A2 Automated systems and methods for analysis of protein post-translational modification |
07/17/2003 | WO2003057829A2 Methods of generating multispecific, multivalent agents from vh and vl domains |
07/17/2003 | WO2003057734A1 Entrapped binding proteins as biosensors |
07/17/2003 | WO2003057730A1 Ligand for g-protein coupled receptor gpr43 and uses thereof |
07/17/2003 | WO2003057719A2 Methods of modulating localization and physiological function of ip3 receptors |
07/17/2003 | WO2003057709A2 Method and reagent for the detection of proteins and peptides |
07/17/2003 | WO2003057521A1 Substance testing devices with photo identification |
07/17/2003 | WO2003057258A2 Quantitative ranking of transient ligand binding to target biomolecules |
07/17/2003 | WO2003057257A1 Cc10 inhibits th2 cytokines and eotaxins involved in allergic diseases |
07/17/2003 | WO2003057252A1 Human mast cell-expressed membrane proteins |
07/17/2003 | WO2003057251A1 Remedies for arthritis |
07/17/2003 | WO2003057238A1 Agents that recognize src when phosphorylated at serine 17 |
07/17/2003 | WO2003057179A2 Use of p97 as an enzyme delivery system for the delivery of therapeutic lysosomal enzymes |
07/17/2003 | WO2003057170A2 Oral insulin therapy |
07/17/2003 | WO2003057168A2 Cancer-associated epitope |
07/17/2003 | WO2003057165A2 COMPOSITIONS AND METHODS FOR PREVENTION AND TREATMENT OF AMYLOID-β PEPTIDE-RELATED DISORDERS |
07/17/2003 | WO2003057159A2 Psoriasin expression by breast epithelial cells |
07/17/2003 | WO2003057156A2 Epithelial cell lines from gene knockout mice and methods of use thereof |
07/17/2003 | WO2003057155A2 Monoclonal antibody imaging and therapy of tumors that express met and bind hepatocyte growth factor |
07/17/2003 | WO2003057148A2 Use of biomolecular targets in the treatment and visualization of tumors |
07/17/2003 | WO2003057130A2 Common lymphatic endothelial and vascular endothelial receptor-1 (clever-1) and uses thereof |
07/17/2003 | WO2003057042A1 Carrier and specimen-handling tool for use in diagnostic testing |
07/17/2003 | WO2003057014A2 Biomarkers for detecting ovarian cancer |
07/17/2003 | WO2003057007A2 System for monitoring bacterial tumor treatment |
07/17/2003 | WO2003057002A2 Diagnostic methods and devices |
07/17/2003 | WO2003056954A1 Method and apparatus for collecting and testing biological samples |
07/17/2003 | WO2003056913A1 Nonhuman model animal lacking the ability to control lymphocyte migration |
07/17/2003 | WO2003056896A2 Use of cytokines secreted by dendritic cells |
07/17/2003 | WO2003042659A3 Rapid prion-detection assay |
07/17/2003 | WO2003038401A3 Semiconductor nanocrystal-based cellular imaging |
07/17/2003 | WO2003035838A3 Stem cells that transform to beating cardiomyocytes |
07/17/2003 | WO2003031595A3 Molecules for disease detection and treatment |
07/17/2003 | WO2003012389A3 Method for analysing macromolecules, analysis device and a method for producing an analysis device |
07/17/2003 | WO2003008646A3 Method for making a self-assembling monolayer and composition |
07/17/2003 | WO2003000896A3 POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNα-5 GENE |
07/17/2003 | WO2002099124A3 Characterising polypeptides |
07/17/2003 | WO2002099044A3 B3galts as modifiers of the p53 pathway and methods of use |
07/17/2003 | WO2002097703A3 Method to identify constituent proteins by peptides profiling |
07/17/2003 | WO2002094259B1 Compounds that inhibit hsp90 and stimulate hsp70 and hsp40, useful in the prevention or treatment of diseases associated with protein aggregation and amyloid formation |
07/17/2003 | WO2002083938A3 Screening methods for identifying ligands |
07/17/2003 | WO2002083928A3 Nucleid acid and corresponding protein entitled 158p3d2 useful in treatment and detection of cancer |
07/17/2003 | WO2002083082A3 Composition and method for destruction of infectious prion proteins |
07/17/2003 | WO2002081646A3 Epitope sequences |
07/17/2003 | WO2002072626A3 Novel form of the phgpx protein as a diagnostic marker for male infertility |
07/17/2003 | WO2002061437A3 Method and system for diagnosing andropause in males |
07/17/2003 | WO2002059286A3 Adenylate cyclases |
07/17/2003 | WO2002058323A3 Method for identifying modulators of bace |
07/17/2003 | WO2002040683A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
07/17/2003 | WO2002031134A3 Novel serine protease genes related to dppiv |
07/17/2003 | WO2002029060A9 Hematopoietin receptors hpr1 and hpr2 |
07/17/2003 | WO2002026998A3 Hydrolases |
07/17/2003 | WO2002023154A3 Aggregation-based assays |
07/17/2003 | WO2002018625A3 Compositions and methods for detecting target microorganisms in a sample |
07/17/2003 | WO2002017858A9 Role of fosb in bone formation |
07/17/2003 | WO2002010767A3 Assay methods for identifying compounds which may protect stratified squamous epithelium against damage by noxious substances |
07/17/2003 | WO2002008469A3 Methods, systems, and articles of manufacture for evaluating biological data |
07/17/2003 | WO2001065260A9 Diagnostic agent for chemotaxis |
07/17/2003 | US20030135875 Models of chronic and acute inflammatory diseases |
07/17/2003 | US20030135332 Circuit and method for pipelined code sequence searching |
07/17/2003 | US20030135108 High throughput screening methods using magnetic resonance imaging agents |
07/17/2003 | US20030135100 Biosensor, iontophoretic sampling system, and methods of use thereof |
07/17/2003 | US20030135096 Animal genetic and health profile database management |
07/17/2003 | US20030135038 Magnetic pigment |
07/17/2003 | US20030135034 Nucleotide sequences coding extracellular membrane proteins; antitumor agents; antiproliferative agents; antiiiflammatory agents; enterotoxins; neuroprotectants |
07/17/2003 | US20030135030 Nanoporous membrane reactor for miniaturized reactions and enhanced reaction kinetics |
07/17/2003 | US20030135026 Compounds and methods for diagnosis of tuberculosis |
07/17/2003 | US20030135025 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
07/17/2003 | US20030134987 Method for determining optimal degree of vulcanization and optimal content of constituent ingredient of composition for vulcanization in real time by impedance measurement and analysis |
07/17/2003 | US20030134865 Modulation of histone deacetylase |
07/17/2003 | US20030134850 Hydrazinyl and nitrogen oxide pyrazoles |
07/17/2003 | US20030134816 Compound capable of modulating the activity and/or expression of hr44, for use in therapy. Hr44 has been cloned from human retinal tissue |
07/17/2003 | US20030134812 Bladder and lower urinary tract syndromes, particularly, irrative symptoms, and to a method of treating same using alpha 1d-adrenergic receptor ( alpha 1dAR) antagonists. The invention further relates to a method of screening compounds |
07/17/2003 | US20030134799 Allosteric modulators of the NMDA receptor and their use in the treatment of CNS disorders and enhancement of CNS function |
07/17/2003 | US20030134791 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
07/17/2003 | US20030134785 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
07/17/2003 | US20030134784 A novel gene (designated 83P2H3) and its encoded protein are described. While 83P2H3 exhibits tissue specific expression in normal adult tissue, it is aberrantly expressed in prostate cancer. 83P2H3 provides a diagnostic and/or theraputic target |
07/17/2003 | US20030134776 Methods for predicting drug sensitivity in patients afflicted with an inflammatory disease |
07/17/2003 | US20030134775 Therapeutic agent of hypertension, a therapeutic agent of angina pectoris, a suppressive agent of cerebrovascular contraction, a therapeutic agent of asthma, a therapeutic agent of peripheral circulation disorder, a prophylactic |
07/17/2003 | US20030134434 Magnetic particles for use in high throughput assays which use a ferrous fluid to concentrate biological substances believed to be sparsely present in large volumes of fluids/urine and as labelling agents |
07/17/2003 | US20030134433 Electronic sensing of chemical and biological agents using functionalized nanostructures |
07/17/2003 | US20030134431 Includes microfluidic channels and electroosmosis for fluorescent detection and monitoring receptor/ligand interactions on substrates; immunoassays; drug screening |
07/17/2003 | US20030134430 Novel amino acid sequences for human caenorhabditis elegans-like protein polypeptides |
07/17/2003 | US20030134429 Wherein sensors are distanced for removal, filtering or reduction in noise interference in protein or DNA/protein microarrays |
07/17/2003 | US20030134425 Method for estimating the sulfur content in the fuel of an internal combustion engine |
07/17/2003 | US20030134386 A fibronectin type III (Fn3) monobody polypeptide consisting of two to six beta -strand domains with a loop region linked between each beta-strand domain, and such polypeptide is capable of binding to a target molecule |
07/17/2003 | US20030134385 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
07/17/2003 | US20030134384 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
07/17/2003 | US20030134383 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
07/17/2003 | US20030134382 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
07/17/2003 | US20030134381 Secreted and transmembrane polypeptides and nucleic acids encoding the same |